December 8, 2020 | by Dr. Chris Martenson | Peak Prosperity |
“The data is 100% in agreement: All studies show a clinical benefit for use of Ivermectin. It works as a pre-exposure prophylaxis, post exposure prophylaxis, and when given to both early and late hospitalized patients.
Early, late, pre and post! 100% of the time it works every time! [play on Anchorman quote there]
As importantly, one study shows a profound improvement in the symptoms for the “long haul” Covid sufferers, for which no other treatments seem to have worked.
If you think you’ve been exposed, or have been exposed, or work in a high risk situation, or you have Covid symptoms, or you are a long haul sufferers, the data is clear: take Ivermectin immediately.
The sooner the better. As is always true of an antiviral. Or antibiotic. That should be crystal clear to everyone except the designers of the tragic RECOVERY trial in the UK, and various W.H.O. study designers. They seem to be a bit dense on the topic for *cough$$$*cough some unknown reason$.”
Ivermectin Meta Data
Meta Review of Ivermectin (Pre-Print) – This is MEGA IMPORTANT!
Ivermectin in Mexico
Ivermectin in Romania
Ivermectin, a potential anticancer drug derived from an antiparasitic drug
Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen
Ivermectin proposes many potentials effects to treat a range of diseases, with its antimicrobial, antiviral, and anti-cancer properties as a wonder drug. It is highly effective against many microorganisms including some viruses. In this comprehensive systematic review, antiviral effects of ivermectin are summarized including in vitro and in vivo studies over the past 50 years. Several studies reported antiviral effects of ivermectin on RNA viruses such as Zika, dengue, yellow fever, West Nile, Hendra, Newcastle, Venezuelan equine encephalitis, chikungunya, Semliki Forest, Sindbis, Avian influenza A, Porcine Reproductive and Respiratory Syndrome, Human immunodeficiency virus type 1, and severe acute respiratory syndrome coronavirus 2. Furthermore, there are some studies showing antiviral effects of ivermectin against DNA viruses such as Equine herpes type 1, BK polyomavirus, pseudorabies, porcine circovirus 2, and bovine herpesvirus 1. Ivermectin plays a role in several biological mechanisms, therefore it could serve as a potential candidate in the treatment of a wide range of viruses including COVID-19 as well as other types of positive-sense single-stranded RNA viruses. In vivo studies of animal models revealed a broad range of antiviral effects of ivermectin, however, clinical trials are necessary to appraise the potential efficacy of ivermectin in clinical setting. https://pubmed.ncbi.nlm.nih.gov/32533071/